Antilymphoma treatments given subsequent to yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin's lymphoma: A review of the literature

Stephen M. Ansell, Russell J. Schilder, Peter C. Pieslor, Leo I. Gordon, Christos Emmanouilides, Katie Vo, Myron S. Czuczman, Thomas E. Witzig, Charles Theuer, Arturo Molina

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Antilymphoma treatments given subsequent to yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin's lymphoma: A review of the literature'. Together they form a unique fingerprint.

Medicine & Life Sciences